Universitätsklinikum Göttingen

Hospital


Location: Göttingen, Germany (DE) DE

ISNI: 0000000104825331

ROR: https://ror.org/021ft0n22

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Aerobic exercise in severe mental illness: requirements from the perspective of sports medicine (2022) Falkai P, Schmitt A, Rosenbeiger CP, Maurus I, Hattenkofer L, Hasan A, Malchow B, et al. Journal article, Review article Generalisierte pustulöse Psoriasis: Überblick zum Status quo und Ergebnisse einer Diskussionsrunde (2022) Reich K, Augustin M, Gerdes S, Ghoreschi K, Kokolakis G, Mößner R, Mrowietz U, et al. Journal article, Review article Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3 (2022) Arora P, Zhang L, Rocha C, Sidarovich A, Kempf A, Schulz S, Cossmann A, et al. Journal article Impact of Time of Surgery on the Outcome after Surgical Stabilization of Rib Fractures in Severely Injured Patients with Severe Chest Trauma-A Matched-Pairs Analysis of the German Trauma Registry (2022) Becker L, Schulz-Drost S, Spering C, Franke A, Dudda M, Kamp O, Lefering R, et al. Journal article Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project) (2022) Bernabei R, Landi F, Calvani R, Cesari M, Del Signore S, Anker SD, Bejuit R, et al. Journal article SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination (2022) Arora P, Kempf A, Nehlmeier I, Graichen L, Winkler MS, Lier M, Schulz S, et al. Journal article EXPECTATION AND ACCEPTANCE OF A CLINICAL DECISION SUPPORT SOFTWARE BY NEPHROLOGIST END-USERS: THE CKDNAPP SURVEY (2022) Kotsis FK, Beachle H, Altenbuchinger M, Meiselbach H, Kosch R, Sabine S, Tanja B, Schultheiss UT Conference contribution A Prospectivly Randomized Phase-II Trial of Axitinib versus Everolimus as Second-Line Therapy in Metastatic Renal Cell Carcinoma (BERAT Study) (2022) Grünwald V, Hilser T, Meiler J, Goebell P, Ivanyi P, Strauss A, Hartmann A, et al. Journal article Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy (2022) Hoffmann M, Sidarovich A, Arora P, Krueger N, Nehlmeier I, Kempf A, Graichen L, et al. Journal article Centrosome-dependent microtubule modifications set the conditions for axon formation (2022) Meka DP, Kobler O, Hong S, Friedrich CM, Wuesthoff S, Henis M, Schwanke B, et al. Journal article